首页> 美国卫生研究院文献>Technology in Cancer Research Treatment >The Effectiveness of Lapatinib in HER2-Positive Metastatic Breast Cancer Patients Pretreated With Multiline Anti-HER2 Treatment: A Retrospective Study in China

【2h】

The Effectiveness of Lapatinib in HER2-Positive Metastatic Breast Cancer Patients Pretreated With Multiline Anti-HER2 Treatment: A Retrospective Study in China

机译：Lapatinib在HER2阳性转移性乳腺癌患者中的有效性与多线抗HER2治疗预处理的患者：中国的回顾性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The aim of this study was to evaluate the effectiveness of lapatinib in human epidermal growth factor receptor 2 (HER2)-positive metastatic breast cancer.

机译：本研究的目的是评估Lapatinib在人表皮生长因子受体2（HER2） - 阳性转移性乳腺癌中的有效性。

著录项

期刊名称 Technology in Cancer Research Treatment
作者
Xinzhao Wang; Lin Wang; Qian Yu; Zhaoyun Liu; Chao Li; Fukai Wang; Zhiyong Yu;
展开▼
作者单位

展开▼
年(卷),期 2021(-1),-1
年度 2021
页码 -1
总页数 9
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词

机译：Lapatinib;Her2阳性;转移性乳腺癌;回顾性研究;目标治疗;

相似文献

外文文献
中文文献
专利

1. Effectiveness of second-line anti-HER2 treatment in HER2-positive metastatic breast cancer patients previously treated with trastuzumab: A real-world study [J] . Wei Zhao, Li Bian, Tao Wang, 中国癌症研究（英文版） . 2020,第003期

机译：二线抗HER2治疗在先前接受曲妥珠单抗治疗的HER2阳性转移性乳腺癌患者中的有效性：一项现实世界研究
2. Real-world effectiveness of post-trastuzumab emtansine treatment in patients with HER2-positive, unresectable and/or metastatic breast cancer: a retrospective observational study (KBCSG-TR 1917) [J] . Nakayama Takahiro, Yoshinami Tetsuhiro, Yasojima Hiroyuki, BMC Cancer . 2021,第1期

机译：患有Her2阳性，不可切除和/或转移性乳腺癌患者术后曲折南方疗养治疗的现实世界效力：回顾性观察研究（KBCSG-TR 1917）
3. Prospective Biomarker Analysis of the Randomized CHER-LOB Study Evaluating the Dual Anti-HER2 Treatment With Trastuzumab and Lapatinib Plus Chemotherapy as Neoadjuvant Therapy for HER2-Positive Breast Cancer [J] . Guarneri Valentina, Dieci Maria Vittoria, Frassoldati Antonio, The oncologist . 2015,第9期

机译：随机CHER-LOB研究的前瞻性生物标记分析，评估曲妥珠单抗和拉帕替尼加化学疗法作为HER2阳性乳腺癌新辅助疗法的双重抗HER2治疗
4. Elevated WBP2 Expression in HER2-Positive Breast Cancers Correlates with Sensitivity to Trastuzumab-Based Neo-Adjuvant Therapy: A Retrospective and Multicentric Study [C] . Yoon Pin Lim International Molecular Medicine Tri-Conference. . 2019

机译：HER2阳性乳腺癌中的WBP2表达升高与基于曲妥珠单抗的新辅助治疗的敏感性相关：回顾性和多中心研究
5. A phase Ib study of safety and pharmacokinetics of trastuzumab emtansine and pertuzumab in Japanese patients with HER2-positive metastatic breast cancer [D] . NOGUCHI, Emi 2019

机译：Ib期研究曲妥珠单抗氨丹宁和帕妥珠单抗在日本HER2阳性转移性乳腺癌患者中的安全性和药代动力学
6. Real-World Data on Apatinib Efficacy - Results of a Retrospective Study in Metastatic Breast Cancer Patients Pretreated With Multiline Treatment [O] . Zhaoyun Liu, Jing Shan, Qian Yu, 2021

机译：关于阿凡替尼疗效的现实世界 - 转移乳腺癌患者的回顾性研究结果进行了多线治疗
7. Effectiveness of second-line anti-HER2 treatment in HER2-positive metastatic breast cancer patients previously treated with trastuzumab: A real-world study [O] . Wei Zhao, Li Bian, Tao Wang, 2020

机译：患有曲妥珠单抗治疗的海绵阳性转移性乳腺癌患者的二线抗HER2治疗的有效性：真实研究

The Effectiveness of Lapatinib in HER2-Positive Metastatic Breast Cancer Patients Pretreated With Multiline Anti-HER2 Treatment: A Retrospective Study in China

摘要

著录项

相似文献

相关主题

期刊订阅